Home/Filings/5/0001144204-13-009373
5//SEC Filing

Rubin Joseph 5

Accession 0001144204-13-009373

CIK 0001175151other

Filed

Feb 13, 7:00 PM ET

Accepted

Feb 14, 5:21 PM ET

Size

6.3 KB

Accession

0001144204-13-009373

Insider Transaction Report

Form 5
Period: 2012-12-31
Rubin Joseph
Director
Transactions
  • Conversion

    Series B Convertible Preferred

    2009-10-05$3620.00/sh+36.2$131,044203.54 total
    Exercise: $0.04Common Stock, par value $0.001 per share (100,000 underlying)
Footnotes (3)
  • [F1]Immediately exercisable
  • [F2]Not Applicable
  • [F3]This amount includes all shares of Series B Convertible Preferred stock issued as quarterly dividend shares. The Series B Convertible Preferred Stock pays dividends quarterly at a rate of 10% per annum. If fully converted, they would be convertible into 562,265 shares of Common Stock

Issuer

Cytosorbents Corp

CIK 0001175151

Entity typeother

Related Parties

1
  • filerCIK 0001368480

Filing Metadata

Form type
5
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 5:21 PM ET
Size
6.3 KB